Assessment of whole body composition with dual energy x-ray absorptiometry in Duchenne muscular dystrophy: Correlation of lean body mass with muscle function

Muscle and Nerve

Volumn 19, Issue 6, 1996, Pages 777-779

  Palmieri, Genaro M A ^a   Bertorini, Tulio E ^b   Griffin, Judy W ^b   Igarashi, Masanori ^b   Karas, James G ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

dual energy x ray absorptiometry; Duchenne muscular dystrophy; lean body mass; muscle function

Indexed keywords

ADOLESCENT; ARTICLE; BODY COMPOSITION; BODY MASS; BONE MINERAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; LEAN BODY WEIGHT; MUSCLE; MUSCLE FUNCTION; MUSCLE STRENGTH; PRIORITY JOURNAL; RADIATION DOSE;

ADOLESCENT; BODY COMPOSITION; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DENSITOMETRY, X-RAY; HUMANS; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0029863002     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199606)19:6<777::AID-MUS15>3.0.CO;2-I     Document Type: Article

References (15)

1. Bertorini TE: Clinical trials in Duchenne muscular dystrophy: the experience in Memphis, Tennessee, in Cornelio F, Di Mauro S, Scarlato G (eds): Muscular Dystrophy Facts and Perspectives. Ital J Neurol Sci 1984;suppl 1:153-158.
2. Bertorini TE, Palmieri GMA, Griffin J, et al.: Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content. Neurology 1985;35:61-65.
3. Bertorini TE, Palmieri GMA, Griffin J, et al.: Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy. Neurology 1988;38:609-613.
4. Dubowitz V: Sewry CA, Fitzsimons RB: Muscle Biopsy: A Practical Approach, 2nd ed. London, Baillière Tindall, 1985, p 291.
5. Edwards RHT, Dawson MJ, Wilkie DR, Gordon RE, Shaw D: Clinical use of nuclear magnetic resonance in the investigations of myopathy. Lancet 1982;i:725-730.
6. Gonzalez D, Mazure R, Mautalen C, Vazquez H, Bai J: Body composition and bone mineral density in untreated and treated patients with celiac disease. Bone 1995;16:231-234.
7. Griffin JW, McClure MH, Bertorini TE: Sequential isokinetic and manual muscle testing in patients with neuromuscular disease. Phys Ther 1986;66:32-35.
8. Haarbo J, Gotfredsen A, Hassager C, Christiansen C: Validation of body composition by dual-energy x-ray absorptiometry (DEXA). Clin Physiol 1991;11:331-341.
9. Heckmatt JZ, Dubowitz V, Leeman S: Detection of pathological change in dystrophic muscle with B-scan ultrasound imaging. Lancet 1980:i:1289-1290.
10. Kanda F, Fujii Y, Takahashi K, Fujita T: Dual-energy x-ray absorptiometry in neuromuscular diseases. Muscle Nerve 1994;17:431-435.
11. Kaplan PA, Matamoros AJ, Anderson JC: Sonography of the musculoskeletal system. Am J Roentgenol 1990;155:237-245.
12. Mazess RB, Barden HS, Bisek JP, Hanson J: Dual-energy x-ray absorptiometry for total body and regional bone-mineral and soft tissue composition. Am J Clin Nutr 1990;51:1106-1112.
13. Murphy WA, Totty WG, Carroll JE: MRI of normal and pathological skeletal muscle. Am J Roentgenol 1986;146:565-574.
14. Schreiber A, Smith WL, Ionasescu Y: Magnetic resonance imaging of children with Duchenne muscular dystrophy. Pediatr Radiol 1987;17:495-497.
15. Slosman DO, Casez JP, Pichard C, et al.: Assessment of wholebody composition with dual-energy x-ray absorptiometry. Radiology 1992;185:593-598.